The Eag potassium channel as a new prognostic marker in ovarian cancer

Diagnostic Pathology

Volumn 5, Issue 1, 2010, Pages

  Asher, Viren ^a   Khan, Raheela ^a   Warren, Averil ^a   Shaw, Robert ^a   Schalkwyk, Gerhard V ^a   Bali, Anish ^a   Sowter, Heidi M ^b  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DERBY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERG1 POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOPSY; CANCER STAGING; CELL PROLIFERATION; DRUG ANTAGONISM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; TIME; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR CELL LINE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CELL LINE, TUMOR; CELL PROLIFERATION; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POTASSIUM CHANNEL BLOCKERS; TIME FACTORS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 78649741809     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-5-78     Document Type: Article

References (23)

1. Cancer Research UK Ovarian Cancer incidence statistics. Cancer Research UK 2005, , http://info.cancerresearchuk.org/cancerstats/types/ovary/
2. Ozols RF. Challenges for chemotherapy in ovarian cancer. Ann Oncol 2006, 17(Suppl 5):v181-7. 10.1093/annonc/mdj978, 16807453.
3. Fiske JL, et al. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 2006, 25(3):493-500. 10.1007/s10555-006-9017-z, 17111226.
4. Pardo LA, et al. Role of voltage-gated potassium channels in cancer. J Membr Biol 2005, 205(3):115-24. 10.1007/s00232-005-0776-1, 16362499.
5. Zhanping W, et al. Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell. Gynecol Oncol 2007, 104(2):455-60. 10.1016/j.ygyno.2006.08.033, 17014896.
6. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004, 19:285-92.
7. Nilius B, Schwarz G, Droogmans G. Control of intracellular calcium by membrane potential in human melanoma cells. Am J Physiol 1993, 265(6 Pt 1):C1501-10.
8. Rouzaire-Dubois B, et al. Control of cell proliferation by cell volume alterations in rat C6 glioma cells. Pflugers Arch 2000, 440(6):881-8. 10.1007/s004240000371, 11041554.
9. Kaplan WD, Trout WE. The behavior of four neurological mutants of Drosophila. Genetics 1969, 61(2):399-409. 1212165, 5807804.
10. Hemmerlein B, et al. Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 2006, 5:41. 10.1186/1476-4598-5-41, 1621079, 17022810.
11. Occhiodoro T, et al. Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. FEBS Lett 1998, 434(1-2):177-82. 10.1016/S0014-5793(98)00973-9, 9738473.
12. Pardo LA, et al. Oncogenic potential of Eag K channels. EMBO J 1999, 18(20):5540-7. 10.1093/emboj/18.20.5540, 1171622, 10523298.
13. Farias LM, et al. Ether a go-go potassium channels as human cervical cancer markers. Cancer Res 2004, 64(19):6996-7001. 10.1158/0008-5472.CAN-04-1204, 15466192.
14. Curran ME, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995, 80(5):795-803. 10.1016/0092-8674(95)90358-5, 7889573.
15. Arcangeli A, et al. A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol 1995, 489(Pt 2):455-71. 1156772, 8847640.
16. Bianchi L, et al. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?. Cancer Res 1998, 58(4):815-22.
17. Cherubini A, et al. HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium. Br J Cancer 2000, 83(12):1722-9. 10.1054/bjoc.2000.1497, 2363441, 11104572.
18. Lastraioli E, et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 2004, 64(2):606-11. 10.1158/0008-5472.CAN-03-2360, 14744775.
19. Pillozzi S, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 2002, 16(9):1791-8. 10.1038/sj.leu.2402572, 12200695.
20. Kononen J, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4(7):844-7. 10.1038/nm0798-844, 9662379.
21. Felipe A, et al. Potassium channels: new targets in cancer therapy. Cancer Detect Prev 2006, 30(4):375-85. 10.1016/j.cdp.2006.06.002, 16971052.
22. Gomez-Varela D, et al. Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 2007, 67(15):7343-9. 10.1158/0008-5472.CAN-07-0107, 17671204.
23. Mello de Queiroz F, et al. Ether a go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer 2006, 5:42. 10.1186/1476-4598-5-42, 1618397, 17022811.